Author: admin

Posters

2009

  • Eandi M, Pradelli L, Iannazzo S. Alanyl-Glutamine Dipeptide (Dipeptiven®) in Total Parenteral Nutrition (TPN) Therapy in Critically Ill Italian Patients: a Pharmacoeconomic Simulation Model. ISPOR 12th Annual European Congress, Paris, France, 24-27 October, 2009
  • Iannazzo S, Pradelli L, Perachino M. Cost-Effectiveness Analysis of Hormonal Therapies in Patients With Advanced Prostate Cancer in Italy. ISPOR 12th Annual European Congress, Paris, France, 24-27 October, 2009
  • Iannazzo S, Sacchi V. A Pharmacoeconomic Evaluation of Influenza Vaccination in the Elderly Population in Italy. ISPOR 12th Annual European Congress, Paris, France, 24-27 October, 2009
  • Iannazzo S , Zaniolo O, Botrugno P. Survey on the Management of Oral Anticoagulation Therapy (Oat) in Italy. ISPOR 12th Annual European Congress, Paris, France, 24-27 October, 2009
  • Dal Negro RW, Pradelli L, Micheletto C, Tognella S, Iannazzo S. Add-on Omalizumab in Persistent Difficult-to-Treat Asthma: a 12-Month Study on Clinical, Economic Outcomes and Related Cost/Utility. ISPOR 12th Annual European Congress, Paris, France, 24-27 October, 2009
  • Eandi M, Pradelli L, Iannazzo S, Chiroli S, Pontoriero G. A Patient-Level Simulation Model for Economic Evaluation of Cinacalcet in the Treatment of Secondary Hyperparathyroidism (SHPT) in Italy. ISPOR 12th Annual European Congress, Paris, France, 24-27 October, 2009
Papers

2008

  • ReadSacchi V. Maraviroc (Celsentri) in HIV treatment. Farmeconomia e percorsi terapeutici 2008; 9(4): 219-222. Edited by AdRes Health Economics & Outcomes Research
  • ReadSacchi V. Telbivudine (Sebivo) in patients with hepatitis B virus (HBV) chronic infection. Farmeconomia e percorsi terapeutici 2008; 9(4): 215-218. Edited by AdRes Health Economics & Outcomes Research
  • ReadPradelli L. Usefulness and limitation of DDD and PDD analyses. 12 months of solid oral antipsychotics prescribing data for the NHS-reimbursed treatment of schizophrenia in Italy. Farmeconomia e percorsi terapeutici 2008; 9(4): 191-196
  • ReadSacchi V. Daptomycin (Cubicin) in patients with complicated skin or soft-tissue infections. Farmeconomia e percorsi terapeutici 2008; 9(3): 163-166. Edited by AdRes Health Economics & Outcomes Research
  • ReadSacchi V. Entecavir (Baraclude) in patients with chronic hepatitis B virus (HPV) infection. Farmeconomia e percorsi terapeutici 2008; 9(3): 157-161. Edited by AdRes Health Economics & Outcomes Research
  • ReadIannazzo S, Pradelli L. Cost-efficacy analysis of hormonal treatments for advanced prostate cancer. Farmeconomia e percorsi terapeutici 2008; 9(3): 147-156
  • ReadZaniolo O, Sacchi V, Pradelli L. Budget impact of vildagliptin. Farmeconomia e percorsi terapeutici 2008; 9(3): 137-146
  • ReadIannazzo S, Pradelli L, Zaniolo O. Pharmacoeconomic analysis of valsartan for the treatment of chronic congestive heart failure in Italy. Farmeconomia e percorsi terapeutici 2008; 9(3): 125-135
  • ReadSacchi V. Rotigotine patches (Neupro) in early Parkinson’s disease. Farmeconomia e percorsi terapeutici 2008; 9(2): 115-119. Edited by AdRes Health Economics & Outcomes Research
  • ReadSacchi V. Natalizumab (Tysabri) in multiple sclerosis patients. Farmeconomia e percorsi terapeutici 2008; 9(2): 109-114. Edited by AdRes Health Economics & Outcomes Research
  • ReadZaniolo O, Iannazzo S. Sartans: differences, similitudes and costs. Farmeconomia e percorsi terapeutici 2008; 9(2): 69-88
  • ReadPradelli L. Parnaparin: review of the literature. Farmeconomia e percorsi terapeutici 2008; 9(1): 27-40
  • ReadIannazzo S, Pradelli L. Solifenacin in overactive bladder syndrome: pharmacoeconomic analysis. Farmeconomia e percorsi terapeutici 2008; 9(1): 5-14
  • ReadIannazzo S, Zaniolo O, Pradelli L. Economic evaluation of treatment with orlistat in Italian obese patients. Curr Med Res Opin 2008; 24(1): 63-74
  • ReadPradelli L, Eandi M. Palonosetron in the prevention of chemotherapy-induced nausea and vomiting (CINV) in Italy: pharmacologic, clinical and economic aspects. Tumori 2008; 94: 26-32
  • ReadCremonesi G, Pradelli L. Profilo farmacologico, clinico ed economico dell’associazione fissa di beclometasone dipropionato e formoterolo in formulazione extra-fine nella terapia di pazienti con asma bronchiale. Profili in Farmacoeconomia 2008; 7
  • ReadZaniolo O, Pradelli L. La schizofrenia: percorsi diagnostico-terapeutici e costo di malattia. Profili in Farmacoeconomia 2008; 6
Podium Presentations

2008

  • Valutazione farmacoeconomica di rituximab nel trattamento dell’artrite reumatoide in Italia. 7° Convegno Nazionale di Farmacoeconomia. Milan, Italy, 9-10 June, 2008.
Posters

2008

  • Iannazzo S, Giuliani G, Zaniolo O, Sacchi V, Pradelli L. New Strategies in the Treatment of Rheumatoid Arthritis Patients in Italy: a Budget Impact Analysis. ISPOR 11th Annual European Congress, Athens, Greece, 8-11 November, 2008
  • Pradelli L, Iannazzo S, Zaniolo O. Cost/Utility Analysis (CUA) of Valsartan for the Treatment of Congestive Heart Failure (CHF) in Italy. ISPOR 11th Annual European Congress, Athens, Greece, 8-11 November, 2008
  • Pradelli L, Iannazzo S. Pharmacoeconomic Evaluation of Solifenacin in the Treatment of Overactive Bladder Syndrome in Italy. ISPOR 11th Annual European Congress, Athens, Greece, 8-11 November, 2008 (PDF)
  • Zaniolo O, Iannazzo S, Bamfi F. Rosiglitazone in the Treatment of Patients With Type 2 Diabetes: Implementation of Budget Impact Analysis Software. SMDM European Congress, 2-4 June, 2008, Engelberg, Switzerland.
  • Iannazzo S, Pradelli L. A Probabilistic Bayesian Markov Model in WinBUGS for the Economic Evaluation of the Treatment With Orlistat of Italian Obese Patients. SMDM European Congress, Engelberg, Switzerland, 2-4 June, 2008
  • Iannazzo S, Pradelli L. Cost Effectiveness of the Cardiovascular Prevention With Ramipril and/or Statins in High Risk Population in Italy. SMDM European Congress, Engelberg, Switzerland, 2-4 June, 2008
Podium Presentations

2007

  • Metodi e scenari di analisi con l’impiego del software di supporto all’analisi decisionale. Seminario ECM Sanofi-Aventis “La prevenzione del rischio cardiovascolare”, Rome, Italy, 9th November, 2007.
  • I modelli di simulazione probabilistica basati su tecniche statistiche bayesiane. Un esempio di valutazione farmacoeconomica della prevenzione del diabete di tipo 2 con orlistat in soggetti obesi. 6° Convegno Nazionale di Farmacoeconomia, Milan, Italy, 25-26 June, 2007.
Posters

2007

  • Eandi M, Zaniolo O, Pradelli L, Iannazzo S. Cost-Effectiveness Analysis and Cost-Utility Analysis of Anti-TNF-α Drugs in Psoriatic Arthritis. ISPOR 10th Annual European Congress, Dublin, Ireland, 20-23 October, 2007 (PDF)
  • Eandi M, Giotta N, Biamino E, Pradelli L, Iannazzo S. Cost-Minimization Analyis of Darbepoetin-α Versus Epoetin-β in Dialysed Patients: a Long-Term Retrospective Monocentric Italian Study. ISPOR 10th Annual European Congress, Dublin, Ireland, 20-23 October, 2007 (PDF)
  • Zaniolo O, Iannazzo S, Bamfi F. Rosiglitazone in the Treatment of Patients With Type 2 Diabetes: Implementation of Budget Impact Analysis Software. ISPOR 10th Annual European Congress, 20-23 October, 2007, Dublin, Ireland.
  • Iannazzo S, Pradelli L. A Probabilistic Bayesian Markov Model in WinBUGS for the Economic Evaluation of the Treatment With Orlistat of Italian Obese Patients. ISPOR 10th Annual European Congress, Dublin, Ireland, 20-23 October, 2007 (PDF)
  • Iannazzo S, Pradelli L. Cost Effectiveness of the Cardiovascular Prevention With Ramipril and/or Statins in High Risk Population in Italy. ISPOR 10th Annual European Congress, Dublin, Ireland, 20-23 October, 2007
Papers

2007

  • ReadDal Negro RW, Eandi M, Pradelli L, Iannazzo S. Cost-effectiveness and healthcare budget impact in Italy of inhaled corticosteroids and bronchodilators for severe and very severe COPD patients. Int J Chron Obstruct Pulmon Dis 2007; 2(2): 169-176
  • ReadPradelli L, Eandi M. Palonosetron in the prevention of chemotherapy-induced nausea and vomiting in Italy: pharmacoeconomic and clinical aspects. Farmeconomia e percorsi terapeutici 2007; 8(2): 71-80
  • ReadZaniolo O, Pradelli L. Il disturbo bipolare: percorsi diagnostico-terapeutici e costo di malattia. Profili in Farmacoeconomia 2007; 4
  • ReadSiracusano A, Niolu C, Pradelli L. Il costo dei disturbi ansiosi e depressivi e l’appropriatezza del percorso diagnostico-terapeutico nel paziente afferente al medico di medicina generale. Profili in Farmacoeconomia 2007; 4
  • ReadSiracusano A, Niolu C, Pradelli L. Profilo farmacologico clinico di paroxetina. Profili in Farmacoeconomia 2007; 4
  • ReadGilli G, Benso L, Pradelli L. Problematiche relative ai criteri auxologici nella diagnosi di bassa statura da deficit di GH e prescrizione dell’ormone della crescita ricombinante. Clinical Management Issues 2007; 1: 165-170
  • ReadPradelli L. Trattamento delle infezioni vaginali in gravidanza con metronidazolo e clotrimazolo topici. Clinical Management Issues 2007; 1(1): 21-29
  • ReadZaniolo O. Pay-back direct to Regions: a new possibility for companies. Farmeconomia e percorsi terapeutici 2007; 8(1): 47-48
  • ReadCosta FV, Zaniolo O. Simvastatin: between clinics and health economics. Farmeconomia e percorsi terapeutici 2007; 8(1): 27-45
  • ReadZaniolo O, Bamfi F, Iannazzo S. Budget impact of rosiglitazone in type 2 diabetes. Farmeconomia e percorsi terapeutici 2007; 8(1): 15-26
  • ReadIannazzo S. Bayesian statistic methods and theri application in probabilistic simulation models. Farmeconomia e percorsi terapeutici 2007; 8(1): 5-13
Posters

2006

  • Eandi M, Iannazzo S, Pradelli L, Patel K, Giuliani G. Cost-Effectiveness of Peginterferon α-2a (40KD) for the Treatment of Chronic Hepatitis B in Italy. ISPOR 9th Annual European Congress, Copenhagen, Denmark, 28-31 October, 2006
  • Pradelli L, Marchettini P, Iannazzo S. Pregabalin vs Gabapentin in the Treatment of Neuropathic Pain in Italy: a Cost-Effectiveness Analysis. ISPOR 9th Annual European Congress, Copenhagen, Denmark, 28-31 October, 2006
  • Eandi M, Iannazzo S, Pradelli L. Prevention With Picotamide and Aspirin in Patients With Type 2 Diabetes Mellitus and Peripheral Arterial Disease: a Pharmacoeconomic Evaluation. ISPOR 9th Annual European Congress, Copenhagen, Denmark, 28-31 October, 2006
Papers

2006

  • ReadIannazzo S. Il progetto SIRIO (Social Impact of Respiratory Integrated Outcomes): un avanzamento nello studio delle patologie croniche respiratorie. Multidisciplinary Respiratory Medicine 2006; 4: 5-6
  • ReadTerrone C, Zaramella S, Zaniolo O. Impatto clinico ed economico dell’ipertrofia prostatica benigna in Italia. Profili in Farmacoeconomia 2006; 3
  • ReadZaniolo O, Pradelli L. Profilo clinico ed economico della tamsulosina. Profili in Farmacoeconomia 2006; 3
  • ReadZaniolo O. L’impatto clinico ed economico dell’infezione da HIV e delle sue terapie in Italia. Profili in Farmacoeconomia 2006; 1
  • ReadEandi M, Pradelli L, Zaniolo O. Principi e scopi della farmacoeconomia. Profili in Farmacoeconomia 2006; 1
  • ReadIannazzo S. The health-economic models: practical aspects and management of uncertainty. Farmeconomia e percorsi terapeutici 2006; 7(4): 239-245
  • ReadEandi M, Zaniolo O. Economic and clinical value of levofloxacin. Farmeconomia e percorsi terapeutici 2006; 7(4): 223-237
  • ReadZaniolo O. Clinical and pharmacoeconomic profile of esomeprazole in acid-related diseases. Farmeconomia e percorsi terapeutici 2006; 7(3): 155-170
  • ReadPradelli L, Zaniolo O. The clinical and economic value of lovastatin in the primary prevention of cardiovascular disease. Farmeconomia e percorsi terapeutici 2006; 7(3): 141-154
  • ReadZaniolo O. Pharmacoeconomic profile of vitamin D3: in the prevention of osteoporosis. Farmeconomia e percorsi terapeutici 2006; 7(1): 71-82
  • ReadZaniolo O, Eandi M. Bayesian statistic methods and their application in probabilistic simulation models. Farmeconomia e percorsi terapeutici 2006; 7(1): 21-35